Status:
UNKNOWN
Using Sensors to Measure Drug Concentrations in Exhaled Breath
Lead Sponsor:
Nadav Goldental
Conditions:
Mental Disorder
Eligibility:
All Genders
18-100 years
Brief Summary
The use of blood tests to measure drug concentrations in psychiatric patients is often a crucial part of monitoring and evaluating the course of treatment. Such tests are commonly conducted as part of...
Eligibility Criteria
Inclusion
- Proper ability to give informed consent
- Psychiatric patients undergoing treatment at Sheba Medical Center
- Patients with treatment plans that require therapeutic drug monitoring
Exclusion
- Involuntary psychiatric hospitalization
- Pregnancy
Key Trial Info
Start Date :
September 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04071145
Start Date
September 1 2019
End Date
October 1 2020
Last Update
August 28 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.